Knockdown of Arginase I Restores NO Signaling in the Vasculature of Old Rats
- 1 February 2006
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hypertension
- Vol. 47 (2), 245-251
- https://doi.org/10.1161/01.hyp.0000198543.34502.d7
Abstract
Arginase, expressed in endothelial cells and upregulated in aging blood vessels, competes with NO synthase (NOS) for l -arginine, thus modulating vasoreactivity and attenuating NO signaling. Moreover, arginase inhibition restores endothelial NOS signaling and l -arginine responsiveness in old rat aorta. The arginase isoform responsible for modulating NOS, however, remains unknown. Because isoform-specific arginase inhibitors are unavailable, we used an antisense (AS) oligonucleotide approach to knockdown arginase I (Arg I). Western blot and quantitative PCR confirmed that Arg I is the predominant isoform expressed in endothelialized aortic rings and is upregulated in old rats compared with young. Aortic rings from 22-month-old rats were incubated for 24 hours with sense (S), AS oligonucleotides, or medium alone (C). Immunohistochemistry, immunoblotting, and enzyme assay confirmed a significant knockdown of Arg I protein and arginase activity in AS but not S or C rings. Conversely, calcium-dependent NOS activity and vascular metabolites of NO was increased in AS versus S or C rings. Acetylcholine (endothelial-dependent) vasorelaxant responses were enhanced in AS versus S or C treated rings. In addition, 1H-oxadiazolo quinoxalin-1-one (10 μmol/L), a soluble guanylyl cyclase inhibitor, increased the phenylephrine response in AS compared with S and C rings suggesting increased NO bioavailability. Finally, l -arginine (0.1 mmol/L)-induced relaxation was increased in AS versus C rings. These data support our hypothesis that Arg I plays a critical role in the pathobiology of age-related endothelial dysfunction. AS oligonucleotides may, therefore, represent a novel therapeutic strategy against age-related vascular endothelial dysfunction.Keywords
This publication has 36 references indexed in Scilit:
- Arterial AgingHypertension, 2005
- Upregulation of Vascular Arginase in Hypertension Decreases Nitric Oxide–Mediated Dilation of Coronary ArteriolesHypertension, 2004
- Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertensionThe FASEB Journal, 2004
- l -Arginine Depletion in Preeclampsia Orients Nitric Oxide Synthase Toward Oxidant SpeciesHypertension, 2004
- Increased arginase activity underlies allergen‐induced deficiency of cNOS‐derived nitric oxide and airway hyperresponsivenessBritish Journal of Pharmacology, 2002
- Increased Expression of Arginase II in Human Diabetic Corpus Cavernosum: In Diabetic-Associated Erectile DysfunctionBiochemical and Biophysical Research Communications, 2001
- Modulation of cholinergic airway reactivity and nitric oxide production by endogenous arginase activityBritish Journal of Pharmacology, 2000
- Molecular cloning of cDNA for nonhepatic mitochondrial arginase (arginase II) and comparison of its induction with nitric oxide synthase in a murine macrophage‐like cell lineFEBS Letters, 1996
- Co-induction of Arginase and Nitric Oxide Synthase in Murine Macrophages Activated by LipopolysaccharideBiochemical and Biophysical Research Communications, 1995
- A physico-chemical comparison of aortic receptors in rat hypertension modelsLife Sciences, 1986